Qingguo Xu, Ph.D.
Massey Cancer Center research program membership
Department of Pharmaceutics,
School of Pharmacy
PhD, University of Oxford, United Kingdom (2009)
MS, Tianjin University, China (2004)
Awards and honors
Genetech Innovation in Biotechnology Award, 2013, American Association of Pharmaceutical Scientists
Award for Research Excellence, 2011, Johns Hopkins Center for Nanomedicine
Trinity College Postgraduate Progress Award, 2007, University of Oxford
One significant focus of my work has been the development of drug-loaded, sub-100 nm, biodegradable nanoparticles with high drug loading and dense PEG coatings for more effective cancer drug delivery, delivered both locally and systemically.
Disease focus of research
Angiogenesis,Cancer therapy resistance,Drug discovery,Translational science
Published research (during tenure as a Massey Cancer Center member)
Search In PubMed